July 8, 2020 / 10:18 AM / a month ago

BRIEF-Angion Initiates Phase 2 Clinical Trial Of Ang-3777 In Patients With Acute Lung Injury Associated With Covid-19 Pneumonia

July 8 (Reuters) - Angion Biomedica:

* ANGION INITIATES PHASE 2 CLINICAL TRIAL OF ANG-3777 IN PATIENTS WITH ACUTE LUNG INJURY ASSOCIATED WITH COVID-19 PNEUMONIA

* ANGION BIOMEDICA- INITIATED IN BRAZIL PHASE 2 CLINICAL TRIAL OF ANG-3777 IN PATIENTS WITH ACUTE LUNG INJURY ASSOCIATED WITH COVID-19 PNEUMONIA

* ANGION SAYS CONDUCTING PHASE 3 REGISTRATION TRIAL OF ANG-3777 TO IMPROVE KIDNEY FUNCTION, REDUCE SEVERITY OF TRANSPLANT-ASSOCIATED ACUTE KIDNEY INJURY Source text for Eikon:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below